<div class="references">
<slot>
    <p><strong>References:</strong> 
    <strong>1.</strong> Rockman-Greenberg C. Hypophosphatasia. Pediatr Endocrinol Rev. 2013;10(suppl 2):380-388. 
    <strong>2.</strong> Medline Plus. ALPL gene: MedlinePlus Genetics. National Library of Medicine. 2018. Accessed March 30, 2023. <a target="_blank" href="https://medlineplus.gov/genetics/gene/alpl/">https://medlineplus.gov/genetics/gene/alpl/</a>
    <strong>3.</strong> Weber TJ, Sawyer EK, Moseley S, et al. Burden of disease in adult patients with hypophosphatasia: results from two patient-reported surveys. Metabolism. 2016;65(10):1522–1530. 
    <strong>4.</strong> Hӧgler W, Langman C, Gomes da Silva H, et al. Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry. BMC Musculoskelet Disord. 2019;20(1):80. 
    <strong>5.</strong> Bianchi ML, Bishop NJ, Guañabens N, et al; Rare Bone Disease Action Group of the European Calcified Tissue Society Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment. Osteoporos Int. 2020;31(8):1445–1460. 
    <strong>6.</strong> Mercimek-Mahmutoglu S, Sidky S, Hyland K, et al. Prevalence of inherited neurotransmitter disorders in patients with movement disorders and epilepsy: a retrospective cohort study. Orphanet J Rare Dis. 2015;10:12.
    <strong>7.</strong> Cellini B, Montioli R, Oppici E, et al. The chaperone role of the pyridoxal 5’-phosphate and its implications for rare diseases involving B6-dependent enzymes. Clin Biochem. 2014;47(3)58–165. 
    <strong>8.</strong> Pierpont EI, Simmons JH, Spurlock KJ, et al. Impact of pediatric hypophosphatasia on behavioral health and quality of life. Orphanet J Rare Dis. 2021;16(1):80. 
    <strong>9.</strong> Mornet E, Nunes ME. Hypophosphatasia. In: Adam MP, Ardinger HH, Pagon RA, et al, eds. GeneReviews®. University of Washington; 2007[KC1] . Accessed March 30, 2023. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/books/NBK1150/">https://www.ncbi.nlm.nih.gov/books/NBK1150/</a>
    <strong>10.</strong> Conti F, Ciullini L, Pugliese G. Hypophosphatasia: clinical manifestation and burden of disease in adult patients. Clin Cases Miner Bone Metab. 2017;14(2):230–234. 
    <strong>11.</strong> Salles JP. Hypophosphatasia: biological and clinical aspects, avenues for therapy. Clin Biochem Rev. 2020;41(1):13–27. 
    <strong>12.</strong> Colazo JM, Hu JR, Dahir KM, et al. Neurological symptoms in hypophosphatasia. Osteoporos Int. 2019;30(2):469–480. 
    <strong>13.</strong> Mornet E. Molecular genetics of hypophosphatasia and phenotype-genotype correlations. Subcell Biochem. 2015;76:25–43. 
    <strong>14.</strong> NORD. Hypophosphatasia. Rare Disease. 2022. Accessed March 30, 2023. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/books/NBK1150/">https://rarediseases.org/rare-diseases/hypophosphatasia/</a>
    <strong>15.</strong> Rush ET, Moseley S, Petryk A. Burden of disease in pediatric patients with hypophosphatasia: results from the HPP Impact Patient Survey and the HPP Outcomes Study Telephone interview. Orphanet J Rare Dis. 2019;14(1):201. 
    <strong>16.</strong> Vieira LHR, Peixoto KC, Fiosi CL, et al. Active search of adult patients with persistently low serum alkaline phosphatase levels for diagnosis of hypophosphatasia. Arch Endocrinol Metab. 2021;65(3):289-294. 
    <strong>17.</strong> Adeli K, Higgins V, Nieuwesteeg M, et al. Biochemical marker reference values across pediatric, adult, and geriatric ages: establishment of robust pediatric and adult reference intervals on the basis of the Canadian Health Measures Survey. Clin Chem. 2015;61(8):1049–1062. 
    <strong>18.</strong> Schumann G, Klauke R, Canalias F, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. Part 9: reference procedure for the measurement of catalytic concentration of alkaline phosphatase. Clin Chem Lab Med. 2011;49(9):1439–1446. 
    <strong>19.</strong> Quest Diagnostics. Alkaline phosphatase. Accessed March 30, 2023. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/books/NBK1150/">https://testdirectory.questdiagnostics.com/test/test-detail/234/alkaline-phosphatase?</a> cc=MASTER
    <strong>20.</strong> LabCorp. Alkaline phosphatase. Accessed March 20, 2023. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/books/NBK1150/">https://www.labcorp.com/tests/ 001107/alkaline-phosphatase#</a>.
    <strong>21.</strong> ARUP Laboratories. Alkaline phosphatase isoenzymes, serum or plasma. Accessed March 30, 2023. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/books/NBK1150/">https://ltd.aruplab.com/Tests/Pub/0021020</a>
    <strong>22.</strong> Colantonio DA, Kyriakopoulou L, Chan MK, et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem. 2012;58(5):854–868. 
    <strong>23.</strong> Bishop N, Munns CF, Ozono K. Transformative therapy in hypophosphatasia. Arch Dis Child. 2016;101(6):514-515. 
    <strong>24.</strong> McKiernan FE, Berg RL, Fuehrer J. Clinical and radiographic findings in adults with persistent hypophosphatasemia. J Bone Miner Res. 2014;29(7):1651–1660. 
    <strong>25.</strong> Whyte MP. Hypophosphatasia: nature’s window on alkaline phosphatase function in humans. In: Bilzikian JP, ed. Principles of Bone Biology. 3rd ed. Academic Press; 2008:1573–1598.
    ­­</p>
</slot>
</div>